Please assess the completion status of the following clinical trial:

Trial Title: Premedication on Sevoflurane Induction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA physical status I-II~* Minor elective surgery~* General anesthesia~Exclusion Criteria:~* Gastroesophageal reflux~* Exhibited a body mass index \> 32 kg/m2~* Took sedative or opioid drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- FM (Type: ACTIVE_COMPARATOR): Premedication consisting of fentanyl 0.6 ug/kg and midazolam 9 ug/kg (FM), five minutes before tidal volume sevoflurane 8% induction with 6 L/min O2.
- NaCl (Type: PLACEBO_COMPARATOR): A 2.5 ml NaCL placebo (NaCl) IV, five minutes before tidal volume sevoflurane 8% induction with 6 L/min O2.

Based on this trial design, predict the completion outcome and termination type (if applicable).